List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 605 studies with search of: "Osteoporosis"
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Active, not recruiting Osteoporosis Choice Decision Aid for Use of Bisphosphonates in Postmenopausal Women
Conditions: Osteoporosis;   Bone Loss, Age Related;   Postmenopausal Bone Loss;   Postmenopausal Osteoporosis
Intervention: Behavioral: Osteoporosis Choice Decision Aid
2 Not yet recruiting A Transiliac Crest Bone Histology and Histomorphometry Study in Postmenopausal Women With Low Bone Mass or Osteoporosis Previously Treated With Denosumab
Conditions: Low Bone Mass;   Low Bone Mineral Density;   Osteoporosis;   Postmenopausal Osteoporosis
Intervention: Procedure: Bone Biopsy
3 Completed Patient- and Physician-Based Osteoporosis Education
Conditions: Osteoporosis;   Osteoporosis, Postmenopausal
Intervention: Behavioral: Osteoporosis Education
4 Active, not recruiting Parathyroid Hormone (PTH) for Osteoporosis in Postmenopausal Women
Conditions: Postmenopausal Osteoporosis;   Osteoporosis
Intervention: Drug: synthetic hPTH 1-34
5 Recruiting Study to Compare the Efficacy and Safety of DenosumAb Versus Placebo in Males With Osteoporosis - The ADAMO Trial
Conditions: Low Bone Mass;   Low Bone Mineral Density;   Males With Osteoporosis;   Osteopenia;   Osteoporosis
Interventions: Drug: 60 mg denosumab;   Other: Placebo
6 Completed A Study to Evaluate Denosumab in the Treatment of Postmenopausal Osteoporosis
Condition: Osteoporosis
Interventions: Drug: placebo;   Drug: denosumab
7 Active, not recruiting Efficacy of Nebido on Bone Mineral Density (BMD) in Hypogonadal Paraplegic Patients With Confirmed Osteoporosis
Conditions: Hypogonadism;   Paraplegia;   Bone Density;   Osteoporosis
Intervention: Drug: Testosterone Undeconate (Nebido-R, BAY86-5037)
8 Completed PROPOSE Quality - PReOtact in Postmenopausal OStEoporosis - Quality of Life Study (FP-004-DE)
Conditions: Postmenopause;   Osteoporosis
Intervention: Drug: Parathyroid hormone (PTH) (Preotact)
9 Recruiting Texture Analysis for Postmenopausal Osteoporosis
Conditions: Osteoporosis;   Osteopenia
Intervention: Drug: Alendronate 70mg
10 Completed Case Control Study: Determinants of Osteoporosis in GOLD II COPD Patients.
Conditions: Chronic Obstructive Pulmonary Disease;   Osteoporosis
Intervention:
11 Not yet recruiting Comparison Study of PTHrP and PTH to Treat Osteoporosis
Condition: Osteoporosis
Interventions: Drug: Parathyroid hormone related protein (1-36);   Drug: Parathyroid hormone related protein(1-36);   Drug: Parathyroid hormone (1-34)
12 Recruiting Strategies to Treat Osteoporosis Following a Fragility Fracture
Conditions: Osteoporosis;   Fragility Fractures
Interventions: Behavioral: Control group;   Behavioral: Minimal Intervention;   Behavioral: Intensive Intervention
13 Active, not recruiting Extension Study to Evaluate the Long Term Safety and Efficacy of Denosumab in the Treatment of Osteoporosis
Conditions: Osteopenia;   Osteoporosis
Intervention: Drug: denosumab
14 Completed The Prevention Of Postmenopausal Osteoporosis With Lasofoxifene And Cytokine Evaluation
Condition: Osteoporosis
Interventions: Drug: Lasofoxifene;   Other: Placebo
15 Completed TOP: Trial of the Effect of Recombinant Human Parathyroid Hormone (ALX1-11) on Fracture Incidence in Women With Postmenopausal Osteoporosis
Condition: Osteoporosis
Intervention: Drug: ALX1-11
16 Completed A Double Blind, Placebo Controlled, Parallel-Group Study to Assess the Safety and Efficacy of 3 Doses of ALX1-11 (50, 75, and 100µg) in the Treatment of Postmenopausal Osteoporosis
Condition: Osteoporosis
Intervention: Drug: ALX1-11
17 Completed Study Evaluating TSE-424/Placebo/Raloxifene in Preventing Osteoporosis in Postmenopausal Women
Condition: Osteoporosis
Intervention: Drug: Bazedoxifene Acetate (TSE-424)
18 Completed Study to Evaluate AMG 162 in the Prevention of Postmenopausal Osteoporosis
Condition: Postmenopausal Osteoporosis
Interventions: Drug: AMG 162;   Drug: Placebo
19 Completed Study of Investigational Drug in Osteoporosis
Condition: Postmenopausal Osteoporosis
Interventions: Drug: MK-0217, alendronate sodium/Duration of Treatment: 3 months;   Drug: Comparator: placebo / Duration of Treatment: 3 months
20 Completed Combination Osteogenic Therapy in Established Osteoporosis
Condition: Osteoporosis, Post-Menopausal
Interventions: Drug: PTH 1-34;   Drug: MFPSR-fluoride

Previous Page Studies Shown (1-20) Next Page (21-40)
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
RSS Feeds for studies found by your search that were:
  First received in the last 14 days,  
  Last updated (includes received) in the last 30 days
  Download Options




Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services